
    
      In this trial, participants will be given dexmedetomidine and ketamine on seperate visits
      using a crossover trial design. fMRI will be conducted during this time. Cognitive
      assessments and pain monitoring will be administered at various points before and after
      ketamine or dexmedetomidine are administered.
    
  